PRNewsWire - Health

Plexium Announces Multiple Presentations at AACR 2025 with Selective Monovalent Degrader Programs Targeting SMARCA2, IKZF2 and CDK2
Welltower Reports First Quarter 2025 Results
AMGEN ANNOUNCES WEBCAST OF 2025 FIRST QUARTER FINANCIAL RESULTS
Privo Technologies Expands CLN-004 Clinical Trial Across Leading U.S. Cancer Centers